January, 2017

WEDNESDAY, Jan. 18, 2017 (HealthDay News) An experimental drug may one day make treatment simpler for patients suffering from vision-threatening age-related macular degeneration, researchers say. So far, the drug -- called AXT107 -- has been only tested on mice and rabbits, but it requires far fewer injections than current therapy to prevent vision loss. Current... read more